| NCT ID | NCT06435819 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Northeastern University |
| Condition | Healthy |
| Study Type | INTERVENTIONAL |
| Enrollment | 300 participants |
| Start Date | 2025-09-05 |
| Primary Completion | 2027-08-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 300 participants in total. It began in 2025-09-05 with a primary completion date of 2027-08-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The investigators will evaluate a computer-animated character that explains medical illustrations to people, comparing the character to having people understand the illustrations on their own, and also comparing the computer character on a computer display to one in immersive virtual reality. The investigators will determine which method leads to the best understanding and lowest anxiety.
Eligibility Criteria
Inclusion Criteria: * Over 18 years old * Speaks English or Spanish fluently * Is able to independently consent * Has adequate corrected vision to read patient education documents Exclusion Criteria: \* None
Contact & Investigator
Timothy Bickmore, PhD
PRINCIPAL INVESTIGATOR
Northeastern University
Frequently Asked Questions
Who can join the NCT06435819 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Healthy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06435819 currently recruiting?
Yes, NCT06435819 is actively recruiting participants. Contact the research team at t.bickmore@northeastern.edu for enrollment information.
Where is the NCT06435819 trial being conducted?
This trial is being conducted at Boston, United States, Boston, United States.
Who is sponsoring the NCT06435819 clinical trial?
NCT06435819 is sponsored by Northeastern University. The principal investigator is Timothy Bickmore, PhD at Northeastern University. The trial plans to enroll 300 participants.